Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 28, 2024 10:17 ET | Source: KBio

KBio Announces FDA Clearance of IND Application for EV68-228-N for the Treatment of Acute Flaccid Myelitis and the First Patient Dosed in the Phase 1 Study

• The United States Food and Drug Administration (FDA) has cleared the investigational new drug (IND) application for EV68-228-N, a human monoclonal IgG1 against the capsid of enterovirus D68 (EV-D68)...
August 01, 2023 08:00 ET | Source: KBio

KBio and ZERO Announce Exclusive Strategic Alliance to Develop a Globally Distributed and Rapidly Deployable Plant-Based Molecular Farming Network

LONDON and VENICE, Italy, Aug. 01, 2023 (GLOBE NEWSWIRE) -- KBio, one of the leading developers of new biological treatments derived from a plant-based production system, and ZERO, an Italian agtech...
September 28, 2022 07:00 ET | Source: Kbio

KBio Announces Strategic Collaboration with Leaf Expression Systems to Enhance Development and Production of Novel Therapeutics

LONDON, Sept. 28, 2022 (GLOBE NEWSWIRE) -- KBio, a leading developer of new biological treatments derived from a plant-based production system, today announced the formation of a strategic...
September 13, 2022 07:00 ET | Source: KBio

KBio Announces Strategic Partnership with ZabBio to Discover and Develop Antibody Therapeutics

Agreement combines drug discovery and plant-based platform expertise to accelerate discovery and development of a new generation of biologics-based medicines for areas of high unmet need KBio...
May 05, 2022 07:00 ET | Source: KBio

KBio Appoints Sean Stevens, Ph.D. as Chief Scientific Officer

LONDON, May 05, 2022 (GLOBE NEWSWIRE) -- KBio, a leading developer of new biological treatments derived from a plant-based production system, today announced the appointment of Sean Stevens, Ph.D....